STOCKHOLDERS’ EQUITY |
12 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 14 - STOCKHOLDERS’ EQUITY
During the years ended June 30, 2025 and 2024, the Company issued and shares of common stock, respectively, to the independent Board of Directors as part of their board compensation. The grant date fair value of the shares was $159,000 for each period, and was recorded as compensation expense in the accompanying consolidated financial statements.
During the year ended June 30, 2025, the Company issued shares of common stock to the CEO for his bonus earned in fiscal year 2024. The fair market value of the shares was $151,201.
During the year ended June 30, 2025, the Company issued shares of common stock to a consultant pursuant to the terms of his consultancy agreement. The grant date fair value of the shares was $8,333 and was recorded as compensation expense in the accompanying consolidated financial statements.
During the year ended June 30, 2024, the Company issued shares of common stock to employees pursuant to the terms of their employment agreements. The grant date fair value of the shares was $9,050 and was recorded as compensation expense in the accompanying consolidated financial statements.
|